Low mood in individuals with schizophrenia: Integrating cognitive performance, structural brain alterations and interleukin-6 levels
Maria Dauvermann,Maria R Dauvermann,Fabiana Corsi-Zuelli,Gary Donohoe,Cristina Marta Del-Ben,Sian Griffiths,Paris Lalousis,Declan McKernan,Derek Morris,John Kelly,Colm McDonald,Carmine Pariante,Nicolas M Barnes,Golam M Khandaker,John Suckling,Bill Deakin,Rachel Upthegrove
DOI: https://doi.org/10.1016/j.psyneuen.2023.106735
IF: 4.693
2024-02-01
Psychoneuroendocrinology
Abstract:Background Depressive symptoms in schizophrenia have been implicated in poor functional outcome, including treatment resistance. Cognitive deficits, reduced structural brain measures (reduced cortical thickness, lower surface area, and reduced volume), and elevated interleukin (IL)-6 may contribute to low mood and fatigue in schizophrenia. Methods We applied structural equation modelling (SEM) to examine the unique and combined relationships between these measures in 44 individuals with established schizophrenia (SZ; 70.5% males, mean age = 44.1; standard deviation (SD) ± 10.8) and 161 healthy controls (HC; 94% males; mean age: 36.4; SD ± 12.5). We ran SEM in two groupings of (i) all participants across SZ and HC and (ii) HC only. Results SEM findings across all participants showed that higher IL-6 levels, but not reduced structural brain measures, predicted greater fatigue (Beta = 0.241, SE = 0.086, p=0.005) and lower mood (Beta = 0.217, SE = 0.086, p=0.012). General cognitive performance was positively related to structural brain changes (Beta = 0.403, SE = 0.062, p<0.001). Furthermore, IL-6 levels were negatively associated with reduced general cognitive performance (Beta = - 0.158, SE = 0.073, p=0.030), however IL-6 was not associated with structural brain alterations. Conclusion These findings suggest that increased IL-6 levels are related to lower mood and higher fatigue across SZ and HC. Currently, we run these SEM analyses in a larger schizophrenia dataset (BeneMin-UK) to replicate these findings. If replicated, these findings may indicate new pathways for further research in depression and schizophrenia.
neurosciences,endocrinology & metabolism,psychiatry